journal article·2020-09Open access

Bispecific T-cell engager (BiTE) immunotherapy of ovarian cancer based on MIL-88A MOF/MC gene delivery system

Jing Zhao, Danping Lu, Sergio Moya, Haoying Yan, Miaojuan Qiu, JunZong Chen, Xincheng Wang, Yang Li, Haobo Pan, Guochuang Chen, Guocheng Wang

Abstract

Abstract Bispecific T-cell engager (BiTE) immunotherapy is a promising therapy for cancer treatment. However, the high cost and short life-time in vivo of the BiTE limit its wide clinical application. Here, we built for the first time a gene delivery system based on MIL-88A metal organic framework nanoparticles and minicricle DNA (MOF/MC) to realize high-efficient in vivo expression of anti-CD3/anti-EpCAM BiTE. X-ray photoelectron spectroscopy (XPS) and dynamic light scattering (DLS) analysis verified that MC molecules were loaded onto MOF nanoparticles through metal-phosphate bonds and electrostatic interactions. It is found that intraperitoneal injection (i.p.) of MOF/MC suspensions showed good transfection performance in mice abdominal cavity with low toxicity. In an intraperitoneal xenograft mice model established using SKOV3 ovarian cells, i.p. injection of MOF/MC.BiTE significantly inhibited tumor growth and prolonged the average survival time of the mice. Overall, our study demonstrates a simple and highly efficient MOF-based gene delivery system holding promise for effective ovarian cancer immunotherapy.
Source: openaire · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: RNA Interference and Gene Delivery · Advanced biosensing and bioanalysis techniques · Nanopore and Nanochannel Transport Studies

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (41)

Show source-provided references
1. Porous metal-organic-framework nanoscale carriers as a potential platform for drug delivery and imaging10.1038/nmat2608 ↗
2. Biomimetic synthesis of coordination network materials: Recent advances in MOFs and MPNs10.1016/j.apmt.2017.12.009 ↗
3. Stimuli-responsive DNA-Functionalized Metal-Organic Frameworks (MOFs)10.1002/adma.201602782 ↗
4. Metal-organic frameworks: functional luminescent and photonic materials for sensing applications10.1039/C6CS00930A ↗
5. Porous Lanthanide Metal-Organic Frameworks for Gas Storage and Separation
6. Bimetallic Metal-Organic Frameworks for Gas Storage and Separation10.1021/acs.cgd.7b00166 ↗
7. Nanoscale metal-organic frameworks for the co-delivery of cisplatin and pooled siRNAs to enhance therapeutic efficacy in drug-resistant ovarian cancer cells10.1021/ja4098862 ↗
8. In vivo targeting and positron emission tomography imaging of tumor with intrinsically radioactive metal-organic frameworks nanomaterials10.1021/acsnano.7b01530 ↗
9. Controllable synthesis of a smart multifunctional nanoscale metal-organic framework for magnetic resonance/optical imaging and targeted drug delivery10.1021/acsami.6b14795 ↗
10. Enzyme-MOF nanoreactor activates nontoxic paracetamol for cancer therapy10.1002/anie.201801378 ↗
11. Size-controlled synthesis of porphyrinic metal-organic framework and functionalization for targeted photodynamic therapy10.1021/jacs.6b00007 ↗
12. Epidemiology of ovarian cancer: a review10.20892/j.issn.2095-3941.2016.0084 ↗
13. Ovarian cancer10.1038/nrdp.2016.61 ↗
14. Gene therapy for lysosomal storage diseases and peroxisomal diseases10.1038/s10038-018-0537-5 ↗
15. New gene therapy strategies for cancer treatment: a review of recent patents10.2174/157489212801820093 ↗
16. PAMAM dendrimers as efficient drug and gene delivery nanosystems for cancer therapy10.1016/j.apmt.2018.05.002 ↗
17. Synthesis of amphiphilic poly(beta-amino ester) for efficiently minicircle DNA delivery in vivo10.1021/acsami.6b04412 ↗
18. Self-assembled peptide-poloxamine nanoparticles enable in vitro and in vivo genome restoration for cystic fibrosis10.1038/s41565-018-0358-x ↗
19. Synthesis and characterization of low molecular weight polyethyleneimine-terminated Poly(beta-amino ester) for highly efficient gene delivery of minicircle DNA10.1016/j.jcis.2015.10.025 ↗
20. Self-Assembled Fluorodendrimers Combine the Features of Lipid and Polymeric Vectors in Gene Delivery10.1002/anie.201501461 ↗
21. Mesoporous silica nanoparticles facilitate delivery of siRNA to shutdown signaling pathways in mammalian cells10.1002/smll.200901966 ↗
22. Fluorescent carbon dots as an efficient siRNA nanocarrier for its interference therapy in gastric cancer cells
23. DNAzyme-Loaded Metal-Organic Frameworks (MOFs) for self-sufficient gene therapy10.1002/anie.201902714 ↗
24. Se/Ru-decorated porous metal-organic framework nanoparticles for the delivery of pooled siRNAs to reversing multidrug resistance in taxol-resistant breast cancer cells10.1021/acsami.6b12792 ↗
25. In Vivo fluorescence imaging of the activity of CEA TCB, a novel T-cell bispecific antibody, reveals highly specific tumor targeting and fast induction of T-cell-mediated tumor killing10.1158/1078-0432.CCR-15-2622 ↗
26. Treatment of human B-cell lymphomas using minicircle DNA vector expressing anti-CD3/CD20 in a mouse model10.1089/hum.2016.122 ↗
27. A non-activating “humanized” anti-CD3 monoclonal antibody retains immunosuppressive properties in vivo10.1097/00007890-199457110-00001 ↗
28. A route to the synthesis of trivalent transition-metal porous carboxylates with trimeric secondary building units10.1002/anie.200454250 ↗
29. Microwave-Assisted Preparation of Inorganic Nanostructures in Liquid Phase10.1021/cr400366s ↗
30. Microwave-assisted solvothermal synthesis and upconversion luminescence of CaF2:Yb3+/Er3+ nanocrystals10.1016/j.jcis.2014.10.031 ↗
31. A robust system for production of minicircle DNA vectors10.1038/nbt.1708 ↗
32. Minicircle DNA vectors devoid of bacterial DNA result in persistent and high-level transgene expression in vivo10.1016/S1525-0016(03)00168-0 ↗
33. Iron-based metal organic framework, MIL-88A, as a heterogeneous persulfate catalyst for decolorization of Rhodamine B in water
34. General and direct method for preparing oligonucleotide-functionalized metal-organic framework nanoparticles10.1021/jacs.7b05633 ↗
35. Treatment of human B-cell lymphomas using minicircle DNA vector expressing anti-CD3/CD20 in a mouse model10.1089/hum.2016.122 ↗
36. The development of bispecific antibodies and their applications in tumor immune escape10.1186/s40164-017-0072-7 ↗
37. Bispecific antibodies10.1016/j.drudis.2015.02.008 ↗
38. Biology and clinical relevance of EpCAM10.15698/cst2019.06.188 ↗
39. Potent immunomodulatory effects of the trifunctional antibody catumaxomab10.1158/0008-5472.CAN-12-4460 ↗
40. Immune-mediated liver injury of the cancer therapeutic antibody catumaxomab targeting EpCAM, CD3 and Fc gamma receptors10.18632/oncotarget.8574 ↗
41. Comparison between NOD/SLID mice and BALB/c mice for patient-derived tumor xenografts model of non-small-cell lung cancer10.2147/CMAR.S181272 ↗